SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-105674
Filing Date
2021-08-16
Accepted
2021-08-16 08:08:24
Documents
64
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q avte-20210630x10q.htm   iXBRL 10-Q 1515872
2 EX-31.1 avte-20210630xex31d1.htm EX-31.1 12241
3 EX-31.2 avte-20210630xex31d2.htm EX-31.2 12263
4 EX-32.1 avte-20210630xex32d1.htm EX-32.1 9304
  Complete submission text file 0001104659-21-105674.txt   5316966

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA avte-20210630.xsd EX-101.SCH 37580
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avte-20210630_cal.xml EX-101.CAL 24719
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avte-20210630_def.xml EX-101.DEF 150093
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE avte-20210630_lab.xml EX-101.LAB 319886
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avte-20210630_pre.xml EX-101.PRE 277436
10 EXTRACTED XBRL INSTANCE DOCUMENT avte-20210630x10q_htm.xml XML 734947
Mailing Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116
Business Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40544 | Film No.: 211174635
SIC: 2834 Pharmaceutical Preparations